Skip to main content
Log in

Drug-induced liver failure due to rivaroxaban

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Abbreviations

DVT:

Deep vein thrombosis

LFT:

Liver function test

ALT:

Alanine aminotransferase

ULN:

Upper limit of normal

AST:

Aspartate aminotransferase

GGT:

Gamma-glutamyltransferase

ALP:

Alkaline phosphatase

INR:

International normalised ratio

DILI:

Drug-induced liver injury

CYP:

Cytochrome P450

References

  1. Harder S, Graff J (2013) Novel oral anticoagulants: clinical pharmacology, indications and practical considerations. Eur J Clin Pharmacol 69:1617–1633

    Article  CAS  Google Scholar 

  2. Caldeira D, Barra M, Santos AT, de Abreu D, Pinto FJ, Ferreira JJ, Costa J (2014) Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis. Heart 100:550–556

    Article  CAS  Google Scholar 

  3. Liakoni E, Rätz Bravo AE, Terracciano L, Heim M, Krahenbuhl S (2014) Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban. JAMA Intern Med 174:1683–1686

    Article  Google Scholar 

  4. Russman S, Niedrig DF, Budmiger M, Schmidt C, Stiger B, Hurlimann S et al (2014) Rvaroxaban postmarketing risk of liver injury. J Hepatol 61:293–300

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All of the above listed authors participated meaningfully in this study and have seen and approved the final manuscript.

Corresponding author

Correspondence to Matthew Peverelle.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest..

Informed consent

Informed consent was obtained from the patient prior to publication of this report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peverelle, M., Asadi, K. & Sinclair, M. Drug-induced liver failure due to rivaroxaban. Ann Hematol 97, 2267–2268 (2018). https://doi.org/10.1007/s00277-018-3364-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-018-3364-z

Navigation